Warren Alden Kibbe

Warren Alden Kibbe

Auto-generated profile, based on publicly available information

Warren Alden Kibbe

Data Science and Strategy, National Cancer Institute, Bethesda, MD

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2008 in Bioinformatics
Verified
Journal Article
Closed access
PDPan Du
Pan Du
WKWarren A. Kibbe
Warren A. Kibbe
SLSimon M. Lin
Simon M. Lin
Summary: Illumina microarray is becoming a popular microarray platform. The BeadArray technology from Illumina makes its preprocessing and quality control different from other microarray technologies. Unfortunately, most other analyses have not taken advantage of the unique properties of the BeadArray system, and have just incorporated preprocessing methods originally designed for Affymetrix microarrays. lumi is a Bioconductor package especially designed to process the Illumina microarray data. It includes data input, quality control, variance stabilization, normalization and gene annotation portions. In specific, the lumi package includes a variance-stabilizing transformation (VST) algorithm that takes advantage of the technical replicates available on every Illumina microarray. Different normalization method options and multiple quality control plots are provided in the package. To better annotate the Illumina data, a vendor independent nucleotide universal identifier (nuID) was devised to identify the probes of Illumina microarray. The nuID annotation packages and output of lumi processed results can be easily integrated with other Bioconductor packages to construct a statistical data analysis pipeline for Illumina data. Availability: The lumi Bioconductor package, www.bioconductor.org Contact: dupan@northwestern.edu

30 November 2010 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
PDPan Du
Pan Du
XZXiao Zhang
Xiao Zhang
CHChiang-Ching Huang
Chiang-Ching Huang
NJNadereh Jafari
Nadereh Jafari
WKWarren A Kibbe
Warren A Kibbe
SLSimon M Lin
Simon M Lin
High-throughput profiling of DNA methylation status of CpG islands is crucial to understand the epigenetic regulation of genes. The microarray-based Infinium methylation assay by Illumina is one platform for low-cost high-throughput methylation profiling. Both Beta-value and M-value statistics have been used as metrics to measure methylation levels. However, there are no detailed studies of their relations and their strengths and limitations.

22 September 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RGRobert L. Grossman
Robert L. Grossman
AHAllison P. Heath
Allison P. Heath
VFVincent Ferretti
Vincent Ferretti
HVHarold E. Varmus
Harold E. Varmus
DLDouglas R. Lowy
Douglas R. Lowy
LSLouis M. Staudt
Louis M. Staudt
For the past 2 years, the National Cancer Institute (NCI), the University of Chicago, the Ontario Institute for Cancer Research, and Leidos Biomedical Research have been developing an information system called the NCI Genomic Data Commons (GDC) (see figure ). The GDC will initially contain raw genomic data as well as diagnostic, histologic, and clinical outcome data from NCI-funded projects such as the Cancer Genome Atlas (TCGA) and the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) program. Unlike previous versions of these data sets, the genomic data will be “harmonized” using uniform analytic pipelines to align the raw sequencing data to the genome and identify mutations, copy-number alterations, and gene-expression changes. The research community can access the GDC through an interactive portal (https://gdc-portal.nci.nih.gov), computer systems can interact through the GDC Application Programming Interface, and developers can suggest new features based on GDC open-source code.

8 May 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
WKWarren A. Kibbe
Warren A. Kibbe
We developed OligoCalc as a web-accessible, client-based computational engine for reporting DNA and RNA single-stranded and double-stranded properties, including molecular weight, solution concentration, melting temperature, estimated absorbance coefficients, inter-molecular self-complementarity estimation and intra-molecular hairpin loop formation. OligoCalc has a familiar ‘calculator’ look and feel, making it readily understandable and usable. OligoCalc incorporates three common methods for calculating oligonucleotide-melting temperatures, including a nearest-neighbor thermodynamic model for melting temperature. Since it first came online in 1997, there have been more than 900 000 accesses of OligoCalc from nearly 200 000 distinct hosts, excluding search engines. OligoCalc is available at http://basic.northwestern.edu/biotools/OligoCalc.html, with links to the full source code, usage patterns and statistics at that link as well.

12 November 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
LSLynn Marie Schriml
Lynn Marie Schriml
CACesar Arze
Cesar Arze
SNSuvarna Nadendla
Suvarna Nadendla
YCYu-Wei Wayne Chang
Yu-Wei Wayne Chang
MMMark Mazaitis
Mark Mazaitis
WKWarren Alden Kibbe
Warren Alden Kibbe
The Disease Ontology (DO) database (http://disease-ontology.org) represents a comprehensive knowledge base of 8043 inherited, developmental and acquired human diseases (DO version 3, revision 2510). The DO web browser has been designed for speed, efficiency and robustness through the use of a graph database. Full-text contextual searching functionality using Lucene allows the querying of name, synonym, definition, DOID and cross-reference (xrefs) with complex Boolean search strings. The DO semantically integrates disease and medical vocabularies through extensive cross mapping and integration of MeSH, ICD, NCI's thesaurus, SNOMED CT and OMIM disease-specific terms and identifiers. The DO is utilized for disease annotation by major biomedical databases (e.g. Array Express, NIF, IEDB), as a standard representation of human disease in biomedical ontologies (e.g. IDO, Cell line ontology, NIFSTD ontology, Experimental Factor Ontology, Influenza Ontology), and as an ontological cross mappings resource between DO, MeSH and OMIM (e.g. GeneWiki). The DO project (http://diseaseontology.sf.net) has been incorporated into open source tools (e.g. Gene Answers, FunDO) to connect gene and disease biomedical data through the lens of human disease. The next iteration of the DO web browser will integrate DO's extended relations and logical definition representation along with these biomedical resource cross-mappings.

10 February 2020 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
BBBrinnae Bent
Brinnae Bent
BGBenjamin A. Goldstein
Benjamin A. Goldstein
WKWarren A. Kibbe
Warren A. Kibbe
Jessilyn DunnJessilyn Dunn
Jessilyn Dunn
As wearable technologies are being increasingly used for clinical research and healthcare, it is critical to understand their accuracy and determine how measurement errors may affect research conclusions and impact healthcare decision-making. Accuracy of wearable technologies has been a hotly debated topic in both the research and popular science literature. Currently, wearable technology companies are responsible for assessing and reporting the accuracy of their products, but little information about the evaluation method is made publicly available. Heart rate measurements from wearables are derived from photoplethysmography (PPG), an optical method for measuring changes in blood volume under the skin. Potential inaccuracies in PPG stem from three major areas, includes (1) diverse skin types, (2) motion artifacts, and (3) signal crossover. To date, no study has systematically explored the accuracy of wearables across the full range of skin tones. Here, we explored heart rate and PPG data from consumer- and research-grade wearables under multiple circumstances to test whether and to what extent these inaccuracies exist. We saw no statistically significant difference in accuracy across skin tones, but we saw significant differences between devices, and between activity types, notably, that absolute error during activity was, on average, 30% higher than during rest. Our conclusions indicate that different wearables are all reasonably accurate at resting and prolonged elevated heart rate, but that differences exist between devices in responding to changes in activity. This has implications for researchers, clinicians, and consumers in drawing study conclusions, combining study results, and making health-related decisions using these devices.